Cargando…
Long-term results of cornea collagen cross-linking with riboflavin for keratoconus
Corneal collagen cross-linking with riboflavin and UVA light (CXL) is the only method designed to arrest the progression of keratoconus. Visual improvement generally starts 3 months after treatment. Reduction is coma seen on aberrometry in early postoperative phase is also responsible for the improv...
Autor principal: | Agrawal, Vinay |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3775082/ https://www.ncbi.nlm.nih.gov/pubmed/23925332 http://dx.doi.org/10.4103/0301-4738.116072 |
Ejemplares similares
-
Collagen cross-linking in thin corneas
por: Padmanabhan, Prema, et al.
Publicado: (2013) -
Management of pediatric keratoconus – Evolving role of corneal collagen cross-linking: An update
por: Kankariya, Vardhaman P, et al.
Publicado: (2013) -
Collagen cross linking: Current perspectives
por: Rao, Srinivas K
Publicado: (2013) -
Newer protocols and future in collagen cross-linking
por: Cummings, Arthur B, et al.
Publicado: (2013) -
Epidemiology of keratoconus
por: Gokhale, Nikhil S
Publicado: (2013)